![](/img/cover-not-exists.png)
B1-05: Activity of MAGE-A3 cancer immunotherapeutic as adjuvant therapy in stage IB/II non-small cell lung cancer (NSCLC): final results of a multi-center, double-blind, randomized, placebo-controlled phase II study
Vansteenkiste, Johan, Zielinksi, Marcin, Linder, Albert, Dahabre, Jubrail, Esteban, Emilio, Malinowski, Wojciech, Jassem, Jacek, Passlick, Bernward, Lehmann, Frédéric, Brichard, Vincent G.Volume:
2
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/01.JTO.0000283143.53176.59
Date:
August, 2007
File:
PDF, 173 KB
english, 2007